AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $901,000 | +14.8% | 66,688 | 0.0% | 0.03% | +10.3% |
| Q3 2020 | $785,000 | -20.2% | 66,688 | 0.0% | 0.03% | -21.6% |
| Q2 2020 | $984,000 | +9.3% | 66,688 | 0.0% | 0.04% | -9.8% |
| Q1 2020 | $900,000 | -44.2% | 66,688 | 0.0% | 0.04% | -32.8% |
| Q4 2019 | $1,612,000 | +25.7% | 66,688 | 0.0% | 0.06% | +8.9% |
| Q3 2019 | $1,282,000 | -35.0% | 66,688 | 0.0% | 0.06% | -30.0% |
| Q2 2019 | $1,971,000 | -39.4% | 66,688 | -2.6% | 0.08% | -39.4% |
| Q1 2019 | $3,254,000 | +132.4% | 68,496 | +76.7% | 0.13% | +120.0% |
| Q4 2018 | $1,400,000 | -41.3% | 38,770 | 0.0% | 0.06% | -31.0% |
| Q3 2018 | $2,386,000 | – | 38,770 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |